Oracle Co. (NYSE:ORCL) Given Average Rating of “Moderate Buy” by Analysts

Shares of Oracle Co. (NYSE:ORCLGet Free Report) have been assigned an average rating of “Moderate Buy” from the thirty ratings firms that are covering the firm, Marketbeat.com reports. Thirteen equities research analysts have rated the stock with a hold recommendation and seventeen have given a buy recommendation to the company. The average 1 year price objective among brokers that have updated their coverage on the stock in the last year is $144.79.

Several equities research analysts have weighed in on ORCL shares. The Goldman Sachs Group increased their target price on shares of Oracle from $115.00 to $130.00 and gave the stock a “neutral” rating in a report on Wednesday, March 13th. JMP Securities reiterated a “market perform” rating on shares of Oracle in a report on Tuesday, June 11th. BMO Capital Markets raised their price objective on shares of Oracle from $142.00 to $160.00 and gave the stock a “market perform” rating in a report on Monday. Deutsche Bank Aktiengesellschaft raised their price objective on shares of Oracle from $150.00 to $165.00 and gave the stock a “buy” rating in a report on Monday. Finally, UBS Group raised their target price on shares of Oracle from $150.00 to $160.00 and gave the company a “buy” rating in a research report on Wednesday, June 12th.

Read Our Latest Research Report on Oracle

Insiders Place Their Bets

In other Oracle news, Director George H. Conrades sold 20,000 shares of Oracle stock in a transaction dated Friday, May 3rd. The shares were sold at an average price of $116.00, for a total value of $2,320,000.00. Following the completion of the sale, the director now owns 17,836 shares in the company, valued at approximately $2,068,976. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director George H. Conrades sold 20,000 shares of the business’s stock in a transaction that occurred on Friday, May 3rd. The shares were sold at an average price of $116.00, for a total value of $2,320,000.00. Following the completion of the transaction, the director now directly owns 17,836 shares in the company, valued at approximately $2,068,976. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Safra Catz sold 790,000 shares of the business’s stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of $126.54, for a total transaction of $99,966,600.00. Following the completion of the transaction, the chief executive officer now owns 1,118,592 shares of the company’s stock, valued at $141,546,631.68. The disclosure for this sale can be found here. Insiders sold 880,000 shares of company stock worth $110,488,150 in the last quarter. 42.80% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Oracle

A number of institutional investors have recently added to or reduced their stakes in the stock. Van ECK Associates Corp grew its holdings in Oracle by 21.5% during the 3rd quarter. Van ECK Associates Corp now owns 35,029 shares of the enterprise software provider’s stock worth $3,710,000 after acquiring an additional 6,187 shares during the last quarter. WealthPlan Investment Management LLC bought a new stake in Oracle during the 3rd quarter worth approximately $214,000. One Capital Management LLC grew its holdings in Oracle by 2.9% during the 3rd quarter. One Capital Management LLC now owns 4,207 shares of the enterprise software provider’s stock worth $446,000 after acquiring an additional 118 shares during the last quarter. Ellevest Inc. grew its holdings in Oracle by 3.2% during the 3rd quarter. Ellevest Inc. now owns 6,118 shares of the enterprise software provider’s stock worth $648,000 after acquiring an additional 189 shares during the last quarter. Finally, Navellier & Associates Inc. bought a new stake in Oracle during the 3rd quarter worth approximately $271,000. 42.44% of the stock is currently owned by institutional investors and hedge funds.

Oracle Price Performance

Shares of ORCL stock opened at $144.64 on Wednesday. Oracle has a 52-week low of $99.26 and a 52-week high of $145.06. The stock has a market cap of $397.54 billion, a PE ratio of 38.99, a PEG ratio of 2.47 and a beta of 1.01. The company has a debt-to-equity ratio of 8.25, a quick ratio of 0.85 and a current ratio of 0.71. The firm’s 50 day moving average price is $121.81 and its two-hundred day moving average price is $116.50.

Oracle (NYSE:ORCLGet Free Report) last announced its quarterly earnings data on Tuesday, June 11th. The enterprise software provider reported $1.63 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.65 by ($0.02). Oracle had a net margin of 19.76% and a return on equity of 223.01%. The business had revenue of $14.29 billion during the quarter, compared to the consensus estimate of $14.57 billion. During the same period in the previous year, the business posted $1.35 earnings per share. Oracle’s revenue was up 3.3% compared to the same quarter last year. As a group, analysts forecast that Oracle will post 5.01 EPS for the current year.

Oracle Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, July 25th. Shareholders of record on Thursday, July 11th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 1.11%. The ex-dividend date is Thursday, July 11th. Oracle’s dividend payout ratio (DPR) is 43.13%.

Oracle Company Profile

(Get Free Report

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Read More

Analyst Recommendations for Oracle (NYSE:ORCL)

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.